Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
Aberrant activation of Janus kinase-3 (Jak3) and its key down-stream effectors, Signal Transducer and Activator of Transcription-3 (STAT3) and STAT5, is a key feature of malignant transformation in cutaneous T-cell lymphoma (CTCL). However, it remains only partially understood how Jak3/STAT activati...
| Main Authors: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Published: |
Impact Journals
2015
|
| Online Access: | https://eprints.nottingham.ac.uk/31257/ |
| _version_ | 1848794161731338240 |
|---|---|
| author | Sibbesen, Nina A. Kopp, Katharina L. Litvinov, Ivan V. Jønson, Lars Willerslev-Olsen, Andreas Fredholm, Simon Petersen, David L. Nastasi, Claudia Krejsgaard, Thorbjørn Lindahl, Lise M. Gniadecki, Robert Mongan, Nigel P. Sasseville, Denis Wasik, Mariusz A. Iversen, Lars Bonefeld, Charlotte M. Geisler, Carsten Woetmann, Anders Odum, Niels |
| author_facet | Sibbesen, Nina A. Kopp, Katharina L. Litvinov, Ivan V. Jønson, Lars Willerslev-Olsen, Andreas Fredholm, Simon Petersen, David L. Nastasi, Claudia Krejsgaard, Thorbjørn Lindahl, Lise M. Gniadecki, Robert Mongan, Nigel P. Sasseville, Denis Wasik, Mariusz A. Iversen, Lars Bonefeld, Charlotte M. Geisler, Carsten Woetmann, Anders Odum, Niels |
| author_sort | Sibbesen, Nina A. |
| building | Nottingham Research Data Repository |
| collection | Online Access |
| description | Aberrant activation of Janus kinase-3 (Jak3) and its key down-stream effectors, Signal Transducer and Activator of Transcription-3 (STAT3) and STAT5, is a key feature of malignant transformation in cutaneous T-cell lymphoma (CTCL). However, it remains only partially understood how Jak3/STAT activation promotes lymphomagenesis. Recently, non-coding microRNAs (miRNAs) have been implicated in the pathogenesis of this malignancy. Here, we show that (i) malignant T cells display a decreased expression of a tumor suppressor miRNA, miR-22, when compared to non-malignant T cells, (ii) STAT5 binds the promoter of the miR-22 host gene, and (iii) inhibition of Jak3, STAT3, and STAT5 triggers increased expression of pri-miR-22 and miR-22. Curcumin, a nutrient with anti-Jak3 activity and histone deacetylase inhibitors (HDACi) also trigger increased expression of pri-miR-22 and miR-22. Transfection of malignant T cells with recombinant miR-22 inhibits the expression of validated miR-22 targets including NCoA1, a transcriptional co-activator in others cancers, as well as HDAC6, MAX, MYCBP, PTEN, and CDK2, which have all been implicated in CTCL pathogenesis. In conclusion, we provide the first evidence that de-regulated Jak3/STAT3/STAT5 signalling in CTCL cells represses the expression of the gene encoding miR-22, a novel tumor suppressor miRNA. |
| first_indexed | 2025-11-14T19:11:48Z |
| format | Article |
| id | nottingham-31257 |
| institution | University of Nottingham Malaysia Campus |
| institution_category | Local University |
| last_indexed | 2025-11-14T19:11:48Z |
| publishDate | 2015 |
| publisher | Impact Journals |
| recordtype | eprints |
| repository_type | Digital Repository |
| spelling | nottingham-312572020-05-04T17:14:46Z https://eprints.nottingham.ac.uk/31257/ Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma Sibbesen, Nina A. Kopp, Katharina L. Litvinov, Ivan V. Jønson, Lars Willerslev-Olsen, Andreas Fredholm, Simon Petersen, David L. Nastasi, Claudia Krejsgaard, Thorbjørn Lindahl, Lise M. Gniadecki, Robert Mongan, Nigel P. Sasseville, Denis Wasik, Mariusz A. Iversen, Lars Bonefeld, Charlotte M. Geisler, Carsten Woetmann, Anders Odum, Niels Aberrant activation of Janus kinase-3 (Jak3) and its key down-stream effectors, Signal Transducer and Activator of Transcription-3 (STAT3) and STAT5, is a key feature of malignant transformation in cutaneous T-cell lymphoma (CTCL). However, it remains only partially understood how Jak3/STAT activation promotes lymphomagenesis. Recently, non-coding microRNAs (miRNAs) have been implicated in the pathogenesis of this malignancy. Here, we show that (i) malignant T cells display a decreased expression of a tumor suppressor miRNA, miR-22, when compared to non-malignant T cells, (ii) STAT5 binds the promoter of the miR-22 host gene, and (iii) inhibition of Jak3, STAT3, and STAT5 triggers increased expression of pri-miR-22 and miR-22. Curcumin, a nutrient with anti-Jak3 activity and histone deacetylase inhibitors (HDACi) also trigger increased expression of pri-miR-22 and miR-22. Transfection of malignant T cells with recombinant miR-22 inhibits the expression of validated miR-22 targets including NCoA1, a transcriptional co-activator in others cancers, as well as HDAC6, MAX, MYCBP, PTEN, and CDK2, which have all been implicated in CTCL pathogenesis. In conclusion, we provide the first evidence that de-regulated Jak3/STAT3/STAT5 signalling in CTCL cells represses the expression of the gene encoding miR-22, a novel tumor suppressor miRNA. Impact Journals 2015-08-21 Article PeerReviewed Sibbesen, Nina A., Kopp, Katharina L., Litvinov, Ivan V., Jønson, Lars, Willerslev-Olsen, Andreas, Fredholm, Simon, Petersen, David L., Nastasi, Claudia, Krejsgaard, Thorbjørn, Lindahl, Lise M., Gniadecki, Robert, Mongan, Nigel P., Sasseville, Denis, Wasik, Mariusz A., Iversen, Lars, Bonefeld, Charlotte M., Geisler, Carsten, Woetmann, Anders and Odum, Niels (2015) Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma. Oncotarget, 6 (24). pp. 20555-20569. ISSN 1949-2553 http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path[]=4111&path[]=8998 |
| spellingShingle | Sibbesen, Nina A. Kopp, Katharina L. Litvinov, Ivan V. Jønson, Lars Willerslev-Olsen, Andreas Fredholm, Simon Petersen, David L. Nastasi, Claudia Krejsgaard, Thorbjørn Lindahl, Lise M. Gniadecki, Robert Mongan, Nigel P. Sasseville, Denis Wasik, Mariusz A. Iversen, Lars Bonefeld, Charlotte M. Geisler, Carsten Woetmann, Anders Odum, Niels Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma |
| title | Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma |
| title_full | Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma |
| title_fullStr | Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma |
| title_full_unstemmed | Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma |
| title_short | Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma |
| title_sort | jak3, stat3, and stat5 inhibit expression of mir-22, a novel tumor suppressor microrna, in cutaneous t-cell lymphoma |
| url | https://eprints.nottingham.ac.uk/31257/ https://eprints.nottingham.ac.uk/31257/ |